DavidMPariserMD

PubMed

• The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic Dermatitis.
  Chien-Chia Chuang, David M Pariser, Eric Simpson, Jennifer Dine, Michelle Brown
  Dermatology and Therapy. 2024-12-01
• 1 citations
  A Pivotal Study on the Safety and Effectiveness of a Targeted Alkali Thermolysis Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating.
  Stacy Smith, Dee Anna Glaser, Lawerence J Green, Micheal S Kaminer, Erin Tims
  Dermatologic Surgery. 2024-12-01
• NivobotulinumtoxinA in the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines in Two Phase 3 Clinical Trials.
  William Coleman, Vince Bertucci, Shannon Humphrey, Joely Kaufman-Janette, Terrence Keaney
  Aesthetic Surgery Journal. 2024-11-26

Journal Articles

• The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis: Results fr...  
  Bissonnette R, Maari C, Forman S, Bhatia N, Lee M, Fowler J, Tyring S,�Pariser�D, Sofen H, Dhawan S, Zook M, Zammit DJ, Usansky H, Denis L, Rao N, Song T, Pavel AB, Gu..., Br J Dermatol, 1/28/2019
• Continued treatment with secukinumab is associated with high retention or regain of response  
  Augustin M, Thaci D, Eyerich K, Pinter A, Radtke M, Lauffer F, Mrowietz U, Gerdes S,�Pariser�D, Lebwohl M, Sieder C, Melzer N, Reich K, Br J Dermatol, 1/10/2019
• Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice  
  Lebwohl M, Alexis AF, Beck LA, Block JK, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Boguniewicz M, J Drugs Dermatol, 1/1/2019
• Glycopyrronium Tosylate in Pediatric Primary Axillary Hyperhidrosis: Post Hoc Analysis of Efficacy and Safety Findings by Age from Two Phase Three Randomized Controlle...  
  Douglass W Forsha, David M Pariser, Adelaide A Hebert, Dee Anna Glaser, William P Werschler, Pediatric Dermatology
• Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled...  
  Gold LS, Lebwohl MG, Sugarman JL, Pariser DM, Lin T, Martin G, Pillai R, Israel R, Ramakrishna T, J Am Acad Dermatol, 1/31/2018
• Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Contro...  
  Pariser DM, Hebert AA, Drew J, Quiring J, Gopalan R, Glaser DA, Am J Clin Dermatol, 1/30/2018
• Long-term safety results from a Phase 3 open-label study of a fixed combination halobetasol propionate 001% and tazarotene 0045% (HP/TAZ) lotion in moderate-to-severe ...  
  Lebwohl MG, Sugarman JL, Gold LS, Pariser DM, Lin T, Pillai R, Martin G, Harris S, Israel R, J Am Acad Dermatol, 1/15/2018
• Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)  
  Kimball AB, Augustin M, Gordon KB, Krueger GG, Pariser D, Fakharzadeh S, Goyal K, Calabro S, Lee S, Lin R, Li N, Srivastava B, Guenther L, Br J Dermatol, 1/10/2018
• Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 Phase 3 Randomized Controlled Trials  
  Glaser DA, Hebert AA, Nast A, Werschler WP, Green L, Mamelok R, Drew J, Quiring J, Pariser DM, J Am Acad Dermatol, 1/9/2018
• Planimetric Post-hoc analysis of women with onychomycosis from tavborole 5% phase III studies: Evidence of greater imporvements in patients with >50% baseline infec...  
  Pariser DM, Wendelken ME, Rycerz AM, Gellings Lowe N, Montgomery Yost J, Lipner SR, J Drugs Dermatol, 1/1/2018
• Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients  
  Zager JS, Gastman BR, Leachman S, Gonzalez RC, Fleming MD, Ferris LK, Ho J, Miller AR, Cook RW, Covington KR, Meldi-Plasseraud K, Middlebrook B, Kaminester LH, Greisin..., BMC Cancer, 1/1/2018
• Understanding Patient Experience With Hyperhidrosis: A National Survey of 1,985 Patients  
  Glaser DA, Hebert A, Pieretti L, Pariser D, J Drugs Dermatol, 1/1/2018
• Introducing a curriculum in ethics and professionalism for dermatology residencies  
  Stoff BK, Grant-Kels JM, Brodell RT, Paller AS, Perlis CS, Mostow E, Pariser D, Bercovitch L, J Am Acad Dermatol, 1/1/2018
• Halobetasol 001%/Tazarotene 0045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy  
  Pariser DM, Green LJ, Stein Gold L, Sugarman JL, Lin T, Pillai R, J Drugs Dermatol, 1/1/2018
• Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 001%/Tazarotene 0045% Fixed Combination  
  Stein Gold L, Kircik LH, Pariser D, Sugarman JL, Lin T, Kang R, Pillai R, J Drugs Dermatol, 1/1/2018
• Novel Tretinoin 005% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older  
  Tyring SK, Kircik LH, Pariser DM, Guenin E, Bhatt V, Pillai R, J Drugs Dermatol, 1/1/2018
• Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies  
  Boguniewicz M, Alexis AF, Beck LA, Block J, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Lebwohl M, J Allergy Clin Immunol Pract, 1/29/2017
• Efficacy and safety of the Janus Kinase 1 inhibitor PF-04965842 in patients with moderate to severe psoriasis: phase 2, randomized, double-blind, placebo-controlled study  
  Schmieder GJ, Draelos ZD, Pariser DM, Banfield C, Cox L, Hodge M, Kieras E, Parsons-Rich D, Menon S, Salganik M, Page K, Peeva E, Br J Dermatol, 1/26/2017
• Apremilast for the treatment of moderate to severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study  
  Bissonnette R, Haydey R, Rosoph L, Lynde CW, Bukhalo M, Fowler J, Delorme I, Gagn�-Henley A, Gooderham M, Poulin Y, Barber K, Jenkin P, Landells I, Pariser D, J Eur Acad Dermatol Venereol, 1/21/2017
• From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis  
  Armstrong AW, Siegel MP, Bagel J, Boh EE, Buell M, Cooper KD, Callis Duffin K, Eichenfield LF, Garg A, Gelfand JM, Gottlieb AB, Koo JY, Korman NJ, Krueger GG, Lebwohl ..., J Am Acad Dermatol, 1/1/2017
• Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 005% Versus Its Vehicle ...  
  Pariser DM, Bukhalo, M, Guenthner S Kempers S, Shideler S, Stein Gold L, Tschen E, Berg J, Ferdon MB, Dromgoole S, J Drugs Dermatol, 1/1/2017
• Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects ...  
  Pariser DM, Krishnaraja J, Tremblay TM, Rubison RM, Love TW, McGraw III MF, J Drugs Dermatol, 1/1/2017
• Dromgoole S Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 005% Versus ...  
  Pariser D, Bukhalo M, Guenthner S, Kempers S, Shideler S, Gold LS, Tschen E, Berg J, Ferdon MB, J Drugs Dermatol, 1/1/2017
• Greater efficacy with secukinumab treatment is associate with greater psoriasis symptom improvement relief: Resuls from secukinumab clinical trials  
  Gottlieb AB, Strober B, Lebwohl M, Kaufmann R, Pariser DM, Narbutas R, Nyirady J, Zhao Y, Herra M, McCleod L, Odom D, Elewski BE, Journal of Psoriasis and Psoriatic Arthritis, 1/1/2017
• Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-...  
  Blauvelt A, de Bruin-Weller M, Gooderham M, Caher JC, Weisman J, Pariser DM, Simpson EL, Papp KA, Hong H Chin-Ho. Rubel D, Foley P, Prens E, Griffiths CEM, Etoh T, Har..., Lancet, 1/1/2017
• Join now to see all

Books/Book Chapters

• Botulinum Toxins in Clinical Aesthetic Practice 
  Chapter: Botulinum toxin in the management of focal hyperhidrosis 
  Pariser DM, Glaser DAEditors: Benedetto A.CRC Press, Taylor and Francis Group, Boca Raton, FLEdition 3rd,2018
• Manual of Obstetrics 
  Chapter: Dermatologic Complications of Pregnancy 
  Pariser DM, Huntley AC, Horney DAEditors: Evans AT and Niswander KR.Lippincott-Raven and Wilkins, Philadelphia, PAEdition 6th,2000
• Care Management of Skin Diseases, Life Quality and Economic Impact 
  Chapter: Strategies for primary care physicians to manage contact dermatitis 
  Pariser DMEditors: Rajagopalan R, Sheretz EF, Adams RT.Marcel Dekker, Inc., New York, NY1998
• Saunders Manual of Medical Practice 
  Pariser DM. HyperhidrosisEditors: Rakel RE.W. B. Saunders Company, Philadelphia, PA1996
• Tecniche Per La Diagnosi Di Malattie Cutanee E Del Capelli 
  Pariser DM, Caserio RJ, Eaglstein WHMicarelli Editore, Rome, Italy1995
• Techniques for Diagnosing Skin and Hair Diseases 
  Pariser DM, Caserio RJ and Eaglstein WHThieme-Stratton, New York, NY1986
• Office Techniques for Diagnosing Skin Diseases 
  Eaglstein WH and Pariser DMYear Book Medical Publishers1978
• Join now to see all

Abstracts/Posters

• Don�t Sweat it: New Drugs for Hyperhidrosis
  Pariser DM, DermFOOT CME Conference, Tysns Corner, VA, 1/13/2019
• Biologics 101: The evolution of biologics
  Pariser DM, DermFOOT CME Conference, Tysns Corner, VA, 1/13/2019
• Scratching the surface: Psoriasis management
  Pariser DM, DermFOOT CME Conference, Tysns Corner, VA, 1/13/2019
• Innovations in hyperhidrosis
  Pariser DM, South Beach Symposium, Miami Beach, FL, 1/9/2019
• Combination therapy in managing psoriasis
  Pariser DM, South Beach Symposium, Miami Beach, FL, 1/9/2019
• Patient cases- psoriasis
  Pariser DM, South Beach Symposium, Miami Beach, FL, 1/9/2019
• Focus Session Director, Updsate on treatment of hyperhidrosis
  Pariser DM, American Academy of Dermatology Annual Meeting, Washington, DC, 1/4/2019
• Efficacy responses with tildrakizumab in moderate-to-severe chronic plaque psoriasis patients with prior exposure to apremilast: results of a pooled analysis of reSURF...
  Gordon K, Reich K, Pariser DM, Menter A, Tyring S,Sofen H, Rozzo S, Parno J, Li Q, La Rosa C, World Psoriasis & Psoriatic Arthritis Conference, Stockholm, Sweden, 1/30/2018
• Efficacy of Tildrakizumab in Moderate to Severe Psoriasis Patients With Prior Exposure to Apremilast
  Gordon KB, Reich K, Pariser DM, Menter A, Tyring SK, Sofen H, Rozzo SJ, Parno J, Li Q, La Rosa C, 5th World Psoriasis and Psoriatic Arthritis Conference, Internal Federation of Psorisis Associations, Stockholm, Sweeden, 1/30/2018
• New and Emerging Therapies
  Pariser DM, Amercan Academy of Dermatology, Chicago, IL, 1/27/2018
• Efficacy and safety of risankizumab, an interleukin-23 inhibitor, in patients with moderate-to-severe chronic plaque psoriasis: 16-week results from the phase III IMMh...
  K.A. Papp, M. Gooderham, R.G. Langley, C. Leonardi, J.-P. Lacour, S. Philipp, S. Tyring, M. Bukhalo, J.J. Wu, J. Bagel, E.H. Frankel, D. Pariser, M. Flack, J. Scherer,..., Societa Italiana di Dermatologia medica, chirurgica, estetica e delle Malattie Sessualmente Trasmesse, Verona, Italy, 1/26/2018
• Clinical and Therapeutic Pearls in medical Dermatology
  Pariser DM, 16th Aniversary Winter Clinical Dermatology Conference, Koloa, HI, 1/23/2018
• Oral psoriasis therapy data and pearls
  Pariser DM, 16th Aniversary Winter Clinical Dermatology Conference, Koloa, HI, 1/23/2018
• Hyperhidrosis update
  Pariser DM, 16th Aniversary Winter Clinical Dermatology Conference, Koloa, HI, 1/23/2018
• Efficacy and safety of IL-23 therapies
  Pariser DM, 16th Aniversary Winter Clinical Dermatology Conference, Koloa, HI, 1/23/2018
• Managing the challenging hyperhidrosis patient
  Pariser DM, 16th Aniversary Winter Clinical Dermatology Conference, Koloa, HI, 1/23/2018
• Coding and reimbursement update
  Pariser DM, 16th Aniversary Winter Clinical Dermatology Conference, Koloa, HI, 1/23/2018
• Dupilumab and Concomitant Topical Corticosteroids in the Long-term Management of Moderate-to-Severe Atopic Dermatitis: Analysis of Clinical Outcomes by Race (LIBERTY A...
  Pariser DM, Lockshin BN, Griffiths CEM, Maui Derm NP+PA Summer, Colorado Springs, CO, 1/23/2018
• Improving your patient interactions: Dealing with the difficult patient
  Pariser DM, Real world dermatology for PA�s and NP�s, Orlando, FL, 1/22/2018
• Evaluating and managing seborrheic keratosis and other benign lesions
  Pariser DM, Real world dermatology for PA�s and NP�s, Orlando, FL, 1/22/2018
• Expert Perspectives on the Management of Moderate-to-Severe Atopic Dermatitis: Addressing Current and Emerging Therapies
  Boguniewicz M, Alexis AF, Beck LA, Block J. Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser DM, Silverberg JI,,1 Lebwohl M, Real World Dermatology for PAs and NPs, Orlando, FL, 1/22/2018
• A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid�Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities
  Jiang SB, Kempers SE, Rich PA, Marcus SL,Piacquadio DJ, Pariser DM, DERM NP and PA Conference, Las Vegas, NV, 1/22/2018
• New Options for Photodymanic Therapy
  Pariser DM, Department of Dermatology, Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University, Medical College of Virginia, New York, NY, 2017; Richmond, VA, 2018, 1/21/2018
• Hands-on patient demonstrations of botulinum toxin for palmar and axillary hyperhidrosis
  Pariser DM, Virginia Commonwealth University, Medical College of Virginia, Richmond, VA, 1/21/2018
• New Therapies for Hyperhidrosis
  Pariser DM, Fall Clinical Dermatology Conference, Las Vegas, NV, 1/21/2018
• Join now to see all

Lectures

• Hyperhidrosis: Update on Therapeutics 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
• International Hyperhidrosis Society Hyperhidrosis Treatment and Practice Excellence 
  American Academy of Dermatology, Hoboken, New Jersey - 9/8/2012
• Managed Care and Dermatology 
  Cleveland, OH, 1994; Boston, MA, 1995 - 1/29/1995
• Managed and Capitated Care - Advantages and Disadvantages 
  San Francisco, CA - 1/31/1994
• Managed Care - Gatekeepers and Capitation 
  San Francisco, CA - 1/30/1994
• Managed Care and Managed Competition: Negotiating a Contract in Which Plans to Participate 
  Houston, TX - 1/24/1994
• Managed Care and Managed Competition: Negotiating a Contract and In Which Plans to Participate 
  Houston, TX - 1/24/1994
• Ethical Dilemmas of Managed Care 
  Philadelphia, PA - 1/22/1994
• Diagnosis and Overview of Onychomycosis 
  Hershey, PA - 1/19/1994
• Treatment of Tinea Versicolor 
  Hershey, PA - 1/19/1994
• Management of Cutaneous Fungal Infections 
  Williamsburg, VA, 1994; Hershey, PA, 1994 - 1/19/1994
• Uncomplicated Cutaneous Candidiasis 
  Hershey, PA - 1/19/1994
• Treatment of Onychomycosis II - New Therapies 
  Hershey, PA - 1/19/1994
• Treatment of Onychomycosis I - Conventional and Traditional Methods 
  Hershey, PA - 1/19/1994
• How to Approach a Nail - Anatomy 
  Hershey, PA - 1/18/1994
• Diagnosis and treatment of cutaneous Candida, Seborrheic Dermatitis and Tinea Versicolor 
  Williamsburg, VA - 1/14/1994
• Relationship of Primary Care Physicians and Dermatologists in Managed Care 
  Williamsburg, VA - 1/14/1994
• How to Manage Managed Care 
  Dana Point, CA - 1/13/1994
• Dermatology and Capitation 
  White Plains, NY, 1993; Laguna Niguel, CA, 1994 - 1/12/1994
• Clinical Manifestations of Fungal Infections 
  Flint, MI - 1/3/1994
• Diagnosis and management of Skin Fungus Infections for the Primary Care Physician 
  Allentown, PA - 1/2/1994
• How Managed Care Will Affect Your Practice 
  San Francisco, CA - 1/1/1994
• Diagnosis and Management of Dermatophyte Infection 
  Alpena, MI - 1/1/1994
• Effects of Finasteride on Dihydrotestosterone Content of Scalp Skin in Men with Male Pattern Baldness 
  1/1/1994
• Topical Steroids in Mild to Severe Dermatoses 
  Myrtle Beach, SC - 1/29/1993
• Join now to see all

Other

• Primary focal hyperhidrosis 
  Pariser D, Smith CC
  http://www.uptodate.com/contents/primary-focal-hyperhidrosis
  UpToDate, Wolters Kluwer Health - 2012-08-14